Act to ban the use of specific antimicrobial drugs in the production of milk, eggs, and honey, aiming to curb antimicrobial ...

“It’s kind of a sexy term” for a drug that rarely includes actual coke, says one researcher, but that hasn’t hurt the popularity of pink cocaine.

Cigna sued Bristol Myers Squibb on Tuesday, accusing the drugmaker of violating U.S. antitrust law by keeping generic versions of its blockbuster blood cancer drug Pomalyst off the market so it ...

A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.

Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly one-quarter of their body weight in early trials.

Ecuador’s most wanted man and leader of the Los Choneros gang, Jose Adolfo Macias, was captured on Wednesday, according to the country’s President Daniel Noboa.

Trump’s most-favored-nation executive order would collapse the American pharmaceutical industry’s innovation edge.

A new study suggests that a medication in the same family as Ozempic could cut the number of days people suffer from migraines by more than half.

The Drug That Could Revolutionize the Fight Against H.I.V. World leaders are dismantling global health programs and cutting back foreign aid.

A groundbreaking wireless implant promises real-time, personalized pain relief using AI and ultrasound power no batteries, no wires, and no opioids. Designed by USC and UCLA engineers, it reads ...

Rivus’ fat-busting, muscle-sparing drug candidate reduced liver fat in a phase 2 trial while showcasing the drug's muscle-sparing potential.

BrightGene is pitting BGM0504 against tirzepatide, the rival GLP-1/GIP drug in Lilly’s Mounjaro and Zepbound, in a phase 2 obesity trial that is scheduled to wrap up next year.